Prevalence of Myositis-Specific Autoantibodies and Myositis-Associated Autoantibodies in COVID-19 Patients: A Pilot Study and Literature Review.

Cureus · 2022 · PMC9617586 · PMID 36324355

Europe PMC DOI

hedged sentence

0.2230

closest p · 4.5× alpha

0.2230

boldest claim

The sentences

did not reach statistical significancep=0.223not close (p > 0.1)

Although a higher prevalence of MSA/MAA positivity was observed within the COVID-19 infected group, the difference did not reach statistical significance (p=0.223).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.